solifenacin placebo

DRUG2 trials

Sponsors

Allergan, IlDong Pharmaceutical Co Ltd

Conditions

Benign Prostate HyperplasiaOveractive BladderUrinary Incontinence

Phase 3

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

CompletedNCT01767519

AllerganOveractive Bladder, Urinary Incontinence

Start: 2013-03-01End: 2015-03-18Updated: 2019-04-23

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

IlDong Pharmaceutical Co LtdBenign Prostate Hyperplasia

Start: 2016-01-31End: 2017-12-31Target: 588Updated: 2016-07-13

Related Papers

The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive Bladder.

2023-10-174 citations